Copyright Reports & Markets. All rights reserved.

Global miRNA Sequencing and Assay Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global miRNA Sequencing and Assay Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global miRNA Sequencing and Assay Market Size 2014-2024
        • 2.1.2 miRNA Sequencing and Assay Market Size CAGR by Region
      • 2.2 miRNA Sequencing and Assay Segment by Type
        • 2.2.1 Sequencing By Synthesis
        • 2.2.2 Nanopore
        • 2.2.3 Ion Semiconductor Sequencing
      • 2.3 miRNA Sequencing and Assay Market Size by Type
        • 2.3.1 Global miRNA Sequencing and Assay Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global miRNA Sequencing and Assay Market Size Growth Rate by Type (2014-2019)
      • 2.4 miRNA Sequencing and Assay Segment by Application
        • 2.4.1 Clinical Medical
        • 2.4.2 Biological Research
      • 2.5 miRNA Sequencing and Assay Market Size by Application
        • 2.5.1 Global miRNA Sequencing and Assay Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global miRNA Sequencing and Assay Market Size Growth Rate by Application (2014-2019)

      3 Global miRNA Sequencing and Assay by Players

      • 3.1 Global miRNA Sequencing and Assay Market Size Market Share by Players
        • 3.1.1 Global miRNA Sequencing and Assay Market Size by Players (2017-2019)
        • 3.1.2 Global miRNA Sequencing and Assay Market Size Market Share by Players (2017-2019)
      • 3.2 Global miRNA Sequencing and Assay Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 miRNA Sequencing and Assay by Regions

      • 4.1 miRNA Sequencing and Assay Market Size by Regions
      • 4.2 Americas miRNA Sequencing and Assay Market Size Growth
      • 4.3 APAC miRNA Sequencing and Assay Market Size Growth
      • 4.4 Europe miRNA Sequencing and Assay Market Size Growth
      • 4.5 Middle East & Africa miRNA Sequencing and Assay Market Size Growth

      5 Americas

      • 5.1 Americas miRNA Sequencing and Assay Market Size by Countries
      • 5.2 Americas miRNA Sequencing and Assay Market Size by Type
      • 5.3 Americas miRNA Sequencing and Assay Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC miRNA Sequencing and Assay Market Size by Countries
      • 6.2 APAC miRNA Sequencing and Assay Market Size by Type
      • 6.3 APAC miRNA Sequencing and Assay Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe miRNA Sequencing and Assay by Countries
      • 7.2 Europe miRNA Sequencing and Assay Market Size by Type
      • 7.3 Europe miRNA Sequencing and Assay Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa miRNA Sequencing and Assay by Countries
      • 8.2 Middle East & Africa miRNA Sequencing and Assay Market Size by Type
      • 8.3 Middle East & Africa miRNA Sequencing and Assay Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global miRNA Sequencing and Assay Market Forecast

      • 10.1 Global miRNA Sequencing and Assay Market Size Forecast (2019-2024)
      • 10.2 Global miRNA Sequencing and Assay Forecast by Regions
        • 10.2.1 Global miRNA Sequencing and Assay Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global miRNA Sequencing and Assay Forecast by Type
      • 10.8 Global miRNA Sequencing and Assay Forecast by Application

      11 Key Players Analysis

      • 11.1 Illumina
        • 11.1.1 Company Details
        • 11.1.2 miRNA Sequencing and Assay Product Offered
        • 11.1.3 Illumina miRNA Sequencing and Assay Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Illumina News
      • 11.2 Thermo Fisher Scientific
        • 11.2.1 Company Details
        • 11.2.2 miRNA Sequencing and Assay Product Offered
        • 11.2.3 Thermo Fisher Scientific miRNA Sequencing and Assay Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Thermo Fisher Scientific News
      • 11.3 Qiagen
        • 11.3.1 Company Details
        • 11.3.2 miRNA Sequencing and Assay Product Offered
        • 11.3.3 Qiagen miRNA Sequencing and Assay Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Qiagen News
      • 11.4 Perkinelmer
        • 11.4.1 Company Details
        • 11.4.2 miRNA Sequencing and Assay Product Offered
        • 11.4.3 Perkinelmer miRNA Sequencing and Assay Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Perkinelmer News
      • 11.5 Takara Bio
        • 11.5.1 Company Details
        • 11.5.2 miRNA Sequencing and Assay Product Offered
        • 11.5.3 Takara Bio miRNA Sequencing and Assay Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Takara Bio News
      • 11.6 Ew England Biolabs
        • 11.6.1 Company Details
        • 11.6.2 miRNA Sequencing and Assay Product Offered
        • 11.6.3 Ew England Biolabs miRNA Sequencing and Assay Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Ew England Biolabs News
      • 11.7 Norgen Biotek Corporation
        • 11.7.1 Company Details
        • 11.7.2 miRNA Sequencing and Assay Product Offered
        • 11.7.3 Norgen Biotek Corporation miRNA Sequencing and Assay Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Norgen Biotek Corporation News
      • 11.8 Rilink Biotechnologies
        • 11.8.1 Company Details
        • 11.8.2 miRNA Sequencing and Assay Product Offered
        • 11.8.3 Rilink Biotechnologies miRNA Sequencing and Assay Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Rilink Biotechnologies News
      • 11.9 Exogen
        • 11.9.1 Company Details
        • 11.9.2 miRNA Sequencing and Assay Product Offered
        • 11.9.3 Exogen miRNA Sequencing and Assay Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Exogen News
      • 11.10 Oxford Nanopore Technologies
        • 11.10.1 Company Details
        • 11.10.2 miRNA Sequencing and Assay Product Offered
        • 11.10.3 Oxford Nanopore Technologies miRNA Sequencing and Assay Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Oxford Nanopore Technologies News

      12 Research Findings and Conclusion

      A microRNA (abbreviated miRNA) is a small non-coding RNA molecule (containing about 22 nucleotides) found in plants, animals and some viruses, that functions in RNA silencing and post-transcriptional regulation of gene expression.

      According to this study, over the next five years the miRNA Sequencing and Assay market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in miRNA Sequencing and Assay business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of miRNA Sequencing and Assay market by product type, application, key companies and key regions.

      This study considers the miRNA Sequencing and Assay value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Sequencing By Synthesis
      Nanopore
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Clinical Medical
      Biological Research

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Illumina
      Thermo Fisher Scientific
      Qiagen
      Perkinelmer
      Takara Bio
      Ew England Biolabs
      Norgen Biotek Corporation
      Rilink Biotechnologies
      Exogen
      Oxford Nanopore Technologies

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global miRNA Sequencing and Assay market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of miRNA Sequencing and Assay market by identifying its various subsegments.
      Focuses on the key global miRNA Sequencing and Assay players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the miRNA Sequencing and Assay with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of miRNA Sequencing and Assay submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now